Cargando…
Glibenclamide does not improve outcome following severe collagenase-induced intracerebral hemorrhage in rats
Intracerebral hemorrhage (ICH) is a devastating insult with few effective treatments. Edema and raised intracranial pressure contribute to poor outcome after ICH. Glibenclamide blocks the sulfonylurea 1 transient receptor potential melastatin 4 (Sur1-Trpm4) channel implicated in edema formation. Whi...
Autores principales: | Kung, Tiffany F. C., Wilkinson, Cassandra M., Dirks, Christine A., Jickling, Glen C., Colbourne, Frederick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174736/ https://www.ncbi.nlm.nih.gov/pubmed/34081746 http://dx.doi.org/10.1371/journal.pone.0252584 |
Ejemplares similares
-
Glibenclamide, a Sur1-Trpm4 antagonist, does not improve outcome after collagenase-induced intracerebral hemorrhage
por: Wilkinson, Cassandra M., et al.
Publicado: (2019) -
A systematic review and meta-analysis on the efficacy of glibenclamide in animal models of intracerebral hemorrhage
por: Kung, Tiffany F. C., et al.
Publicado: (2023) -
Colchicine pre-treatment and post-treatment does not worsen bleeding or functional outcome after collagenase-induced intracerebral hemorrhage
por: Wilkinson, Cassandra M., et al.
Publicado: (2022) -
An Ambiguous Role for Fever in Worsening Outcome After Intracerebral Hemorrhage
por: Liddle, Lane J., et al.
Publicado: (2022) -
Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat
por: Liddle, Lane, et al.
Publicado: (2019)